State Street’s Nephros NEPH Stock Holding History

State Street’s Portfolio NEPH Stock Details NEPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$58.2K	Hold	15,698	–	–	﹤0.01%	4158
2026 Q2	$56K	Hold	15,698	–	–	﹤0.01%	4120
2026 Q1	$46.8K	Hold	15,698	–	–	﹤0.01%	4136
2025 Q4	$76.6K	Hold	15,698	–	–	﹤0.01%	4091
2025 Q3	$74.3K	Hold	15,698	–	–	﹤0.01%	4098
2025 Q2	$64.2K	Hold	15,698	–	–	﹤0.01%	4052
2025 Q1	$27K	Hold	15,698	–	–	﹤0.01%	4171
2024 Q4	$22.9K	Hold	15,698	–	–	﹤0.01%	4224
2024 Q3	$26.8K	Hold	15,698	–	–	﹤0.01%	4192
2024 Q2	$33.1K	Hold	15,698	–	–	﹤0.01%	4215
2024 Q1	$34.4K	Hold	15,698	–	–	﹤0.01%	4219
2023 Q4	$54.2K	Hold	15,698	–	–	﹤0.01%	4182
2023 Q3	$23.5K	Hold	15,698	–	–	﹤0.01%	4426
2023 Q2	$24.3K	Hold	15,698	–	–	﹤0.01%	4570
2023 Q1	$17.1K	Hold	15,698	–	–	﹤0.01%	4702
2022 Q4	$17.6K	Hold	15,698	–	–	﹤0.01%	4755
2022 Q3	$14K	Hold	15,698	–	–	﹤0.01%	4870
2022 Q2	$24K	Buy	+15,698	New	+$42.4K	﹤0.01%	4855

Other funds holding NEPH

Massachusetts Institute of Technology Cambridge, Massachusetts $695M AUM 43.77% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $763M AUM 59.25% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Meritage Group San Francisco, California $2.78B AUM 9.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Bard Associates Chicago, Illinois $431M AUM 30.93% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Mesirow Financial Investment Management Chicago, Illinois $6.47B AUM 15.41% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

State Street's NEPH Position: Q3 2026 in Review

State Street held its Nephros (NEPH) position steady in Q3 2026 at 15,698 shares worth $58.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4158.

State Street first reported a position in NEPH in Q2 2022 and has held it in 18 quarters since. The position peaked at $76.6K in Q4 2025. 26 funds tracked by Wall St. Rank hold NEPH as of Q3 2026.

State Street held 15,698 shares of Nephros worth $58.2K as of Q3 2026.
State Street left its Nephros share count unchanged in Q3 2026.
Nephros made up ﹤0.01% of State Street's portfolio in Q3 2026, its #4158 holding.
State Street first reported a position in Nephros in Q2 2022 and has held it in 18 quarters since.
State Street's Nephros position peaked at $76.6K in Q4 2025.
26 funds tracked by Wall St. Rank held Nephros as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.